Developer of urine-linked drug files to raise $15M through public offering
November 12, 2018 at 14:51 PM EST
The Plymouth-based company plans to put proceeds from the offering toward further development of its drug candidate, DM199.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.